Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Simultaneous filing of a Common Technical Document for Amevive in the U.S. and Europe

Aug. 8, 2001

Allergan expands dermatology collaboration with Cytochroma

Aug. 8, 2001

MBI-594AN phase II clinical trial for acne completes enrollment

Aug. 6, 2001

Results from pivotal phase III trials on Xanelim for psoriasis presented

Aug. 2, 2001

Biogen's Amevive shows good results as therapy for psoriasis

Aug. 2, 2001

Infliximab effective against plaque-type psoriasis

Aug. 1, 2001

MedImmune begins additional study of siplizumab in psoriasis patients

July 27, 2001

Dusa cleared to begin three phase I/II trials with Levulan for new indications

July 26, 2001

Novel inhibitor of cPLA2 with topical and oral antiinflammatory activity

July 24, 2001

First launch for diclofenac gel formulation for actinic keratoses

July 20, 2001

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...